Market Cap 887.48M
Revenue (ttm) 560,000.00
Net Income (ttm) -88.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -15,823.21%
Debt to Equity Ratio 0.00
Volume 634,200
Avg Vol 1,167,974
Day's Range N/A - N/A
Shares Out 60.21M
Stochastic %K 78%
Beta 1.45
Analysts Strong Sell
Price Target $35.80

Company Profile

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elev...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 3457 6900
Address:
12 Hammersmith Grove, London, United Kingdom
StockConsultant
StockConsultant Sep. 2 at 1:14 PM
$SLN Silence Therapeutics stock, nice breakout, from Stocks to Watch at https://www.stockconsultant.com/?SLN
0 · Reply
stockwitsuser2449
stockwitsuser2449 Sep. 1 at 8:09 PM
$SLN here is the data for you "gurus"
0 · Reply
stockwitsuser2449
stockwitsuser2449 Sep. 1 at 8:04 PM
$SLN while this is not traded on all brokers as stock the options are available...gained here before from a previous spike playing options on the expected downside. making similar case again. there is unusually high implied volatility on the downside puts, although kind of show i have seen here before. September OTM puts reaching ~790% IV, while October also shows extremely elevated downside IV. This doesn’t mean the market is predicting a specific price—it means downside protection is extremely expensive, suggesting traders are pricing significant tail risk into the September/October expirations. If selling of some of those shares from last months offer starts, the options structure suggests the potential for a sharp, nonlinear move lower rather than a normal gradual pullback. watch for 12.50 over the next 2 months and play caustiously glta
0 · Reply
LIGator
LIGator Sep. 1 at 7:29 PM
$GLSI $SLN I have owned both for years. Both are among my top holdings. I don’t think that SLN would catch GLSI in share price, but we are almost there. GLSI is overdue for a rally.
1 · Reply
BBRC
BBRC Aug. 28 at 4:47 PM
$NVS $IONS $NAMS $SLN Yes. The trial officially finished its core patient tracking phase in July 2026. Now they must execute a multi-month cleaning phase before unblinding the data. Phase 3 Horizon topline results are expected to hit the tape in late 2026 or early 2027.
0 · Reply
Elessar66
Elessar66 Aug. 28 at 3:15 PM
$SLN Ph3 study start in 1H27. Mgmt will share detailed Ph2 data at on December 12–15, 2026. they intend to advance divesiran as quickly as possible and will share details on the Ph3 trial design post alignment with the FDA, but has already decided to advance the convenient dose
1 · Reply
masonat
masonat Aug. 28 at 1:50 PM
$NVS $IONS $NAMS $SLN HORIZON finally finished. Results should be soon.
0 · Reply
JeremyDanie
JeremyDanie Aug. 28 at 1:46 PM
$SLN Anyone see a catalyst for these shares before year-end?
0 · Reply
JeremyDanie
JeremyDanie Aug. 28 at 2:12 AM
$SLN how long will $SLN be pinned at $13.50?
0 · Reply
laaarsas
laaarsas Aug. 22 at 10:46 AM
$SLN more of this bullshit until Lp(a) data?
0 · Reply
Latest News on SLN
Silence Therapeutics 13M share Secondary priced at $13.50

2026-08-17T10:17:18.000Z - 16 days ago

Silence Therapeutics 13M share Secondary priced at $13.50


Silence Therapeutics 13M share Secondary priced at $13.50

2026-08-17T10:17:13.000Z - 16 days ago

Silence Therapeutics 13M share Secondary priced at $13.50


Silence Therapeutics files to sell $150M in ADS’s

2026-08-10T20:35:32.000Z - 23 days ago

Silence Therapeutics files to sell $150M in ADS’s


Silence Therapeutics Transcript: Study result

Aug 10, 2026, 8:00 AM EDT - 23 days ago

Silence Therapeutics Transcript: Study result


Silence Therapeutics Press release: Study result

Aug 10, 2026, 8:00 AM EDT - 23 days ago

Silence Therapeutics Press release: Study result


Silence Therapeutics Slides: Study result

Aug 10, 2026, 8:00 AM EDT - 23 days ago

Silence Therapeutics Slides: Study result


Silence Therapeutics reports Q2 EPS (9c), consensus (17c)

2026-08-10T11:20:17.000Z - 23 days ago

Silence Therapeutics reports Q2 EPS (9c), consensus (17c)


Silence Therapeutics Earnings release: Q2 2026

Aug 10, 2026, 7:00 AM EDT - 23 days ago

Silence Therapeutics Earnings release: Q2 2026


Silence Therapeutics Quarterly report: Q2 2026

Aug 10, 2026, 7:00 AM EDT - 23 days ago

Silence Therapeutics Quarterly report: Q2 2026


Silence Therapeutics Slides: Corporate presentation

Jun 23, 2026, 7:00 AM EDT - 2 months ago

Silence Therapeutics Slides: Corporate presentation


Silence Therapeutics files $300M ordinary shares offering

2026-05-18T20:16:33.000Z - 3 months ago

Silence Therapeutics files $300M ordinary shares offering


Silence Therapeutics Registration statement: Registration filing

May 18, 2026, 8:00 AM EDT - 3 months ago

Silence Therapeutics Registration statement: Registration filing


Silence Therapeutics reports Q1 EPS (11c) vs. (20c) last year

2026-05-07T13:21:52.000Z - 3 months ago

Silence Therapeutics reports Q1 EPS (11c) vs. (20c) last year


Silence Therapeutics Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Silence Therapeutics Earnings release: Q1 2026


Silence Therapeutics Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Silence Therapeutics Quarterly report: Q1 2026


Silence Therapeutics Slides: Corporate presentation

May 6, 2026, 7:00 AM EDT - 3 months ago

Silence Therapeutics Slides: Corporate presentation


Silence Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Silence Therapeutics Proxy statement: Proxy filing


Silence Therapeutics Annual report: Q4 2025

Mar 5, 2026, 7:30 AM EST - 6 months ago

Silence Therapeutics Annual report: Q4 2025


Silence Therapeutics Earnings release: Q4 2025

Mar 5, 2026, 7:30 AM EST - 6 months ago

Silence Therapeutics Earnings release: Q4 2025


Silence Therapeutics Annual report: Q4 2025

Mar 5, 2026, 7:30 AM EST - 6 months ago

Silence Therapeutics Annual report: Q4 2025


Silence Therapeutics CEO Craig Tooman to end employment

2025-12-15T13:20:39.000Z - 8 months ago

Silence Therapeutics CEO Craig Tooman to end employment


Silence Therapeutics Announces Leadership Changes

Dec 15, 2025, 8:13 AM EST - 8 months ago

Silence Therapeutics Announces Leadership Changes


Silence Therapeutics reports Q3 EPS (15c), consensus (21c)

2025-11-06T14:06:04.000Z - 10 months ago

Silence Therapeutics reports Q3 EPS (15c), consensus (21c)


Silence Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:30 AM EST - 10 months ago

Silence Therapeutics Quarterly report: Q3 2025


Silence Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:30 AM EST - 10 months ago

Silence Therapeutics Earnings release: Q3 2025


Silence Therapeutics completes patient enrollment in SANRECO

2025-10-23T11:41:01.000Z - 10 months ago

Silence Therapeutics completes patient enrollment in SANRECO


Silence Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Silence Therapeutics Quarterly report: Q2 2025


Silence Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Silence Therapeutics Earnings release: Q2 2025


Silence Therapeutics Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Silence Therapeutics Proxy statement: Proxy Filing


Silence Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Silence Therapeutics Quarterly report: Q1 2025


Silence Therapeutics Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Silence Therapeutics Earnings release: Q1 2025


Silence Therapeutics Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Silence Therapeutics Proxy statement: Proxy Filing


Silence Therapeutics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Silence Therapeutics Earnings Call Transcript: Q4 2024


Silence Therapeutics Annual report: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Silence Therapeutics Annual report: Q4 2024


Silence Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Silence Therapeutics Earnings release: Q4 2024


Silence Therapeutics Slides: Q4 2024

Feb 27, 2025, 8:00 AM EST - 1 year ago

Silence Therapeutics Slides: Q4 2024


Silence Therapeutics Earnings release: Q3 2024

Nov 25, 2024, 2:00 AM EST - 1 year ago

Silence Therapeutics Earnings release: Q3 2024


Silence Therapeutics Earnings release: Q2 2024

Aug 15, 2024, 8:00 AM EDT - 2 years ago

Silence Therapeutics Earnings release: Q2 2024


Silence Therapeutics Transcript: Study Result

Jun 27, 2024, 8:30 AM EDT - 2 years ago

Silence Therapeutics Transcript: Study Result


Silence Therapeutics Press release: Study Result

Jun 27, 2024, 8:30 AM EDT - 2 years ago

Silence Therapeutics Press release: Study Result


Silence Therapeutics Slides: Study Result

Jun 27, 2024, 8:30 AM EDT - 2 years ago

Silence Therapeutics Slides: Study Result


Silence Therapeutics Earnings release: Q1 2024

May 16, 2024, 7:00 AM EDT - 2 years ago

Silence Therapeutics Earnings release: Q1 2024


Silence Therapeutics Earnings Call Transcript: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Silence Therapeutics Earnings Call Transcript: Q4 2023


Silence Therapeutics Annual report: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Silence Therapeutics Annual report: Q4 2023


Silence Therapeutics Earnings release: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Silence Therapeutics Earnings release: Q4 2023


Silence Therapeutics Slides: Q4 2023

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Silence Therapeutics Slides: Q4 2023


Silence Therapeutics Earnings release: Q3 2023

Nov 14, 2023, 7:00 AM EST - 2 years ago

Silence Therapeutics Earnings release: Q3 2023


Silence Therapeutics Transcript: Study Update

Nov 13, 2023, 12:00 PM EST - 2 years ago

Silence Therapeutics Transcript: Study Update


StockConsultant
StockConsultant Sep. 2 at 1:14 PM
$SLN Silence Therapeutics stock, nice breakout, from Stocks to Watch at https://www.stockconsultant.com/?SLN
0 · Reply
stockwitsuser2449
stockwitsuser2449 Sep. 1 at 8:09 PM
$SLN here is the data for you "gurus"
0 · Reply
stockwitsuser2449
stockwitsuser2449 Sep. 1 at 8:04 PM
$SLN while this is not traded on all brokers as stock the options are available...gained here before from a previous spike playing options on the expected downside. making similar case again. there is unusually high implied volatility on the downside puts, although kind of show i have seen here before. September OTM puts reaching ~790% IV, while October also shows extremely elevated downside IV. This doesn’t mean the market is predicting a specific price—it means downside protection is extremely expensive, suggesting traders are pricing significant tail risk into the September/October expirations. If selling of some of those shares from last months offer starts, the options structure suggests the potential for a sharp, nonlinear move lower rather than a normal gradual pullback. watch for 12.50 over the next 2 months and play caustiously glta
0 · Reply
LIGator
LIGator Sep. 1 at 7:29 PM
$GLSI $SLN I have owned both for years. Both are among my top holdings. I don’t think that SLN would catch GLSI in share price, but we are almost there. GLSI is overdue for a rally.
1 · Reply
BBRC
BBRC Aug. 28 at 4:47 PM
$NVS $IONS $NAMS $SLN Yes. The trial officially finished its core patient tracking phase in July 2026. Now they must execute a multi-month cleaning phase before unblinding the data. Phase 3 Horizon topline results are expected to hit the tape in late 2026 or early 2027.
0 · Reply
Elessar66
Elessar66 Aug. 28 at 3:15 PM
$SLN Ph3 study start in 1H27. Mgmt will share detailed Ph2 data at on December 12–15, 2026. they intend to advance divesiran as quickly as possible and will share details on the Ph3 trial design post alignment with the FDA, but has already decided to advance the convenient dose
1 · Reply
masonat
masonat Aug. 28 at 1:50 PM
$NVS $IONS $NAMS $SLN HORIZON finally finished. Results should be soon.
0 · Reply
JeremyDanie
JeremyDanie Aug. 28 at 1:46 PM
$SLN Anyone see a catalyst for these shares before year-end?
0 · Reply
JeremyDanie
JeremyDanie Aug. 28 at 2:12 AM
$SLN how long will $SLN be pinned at $13.50?
0 · Reply
laaarsas
laaarsas Aug. 22 at 10:46 AM
$SLN more of this bullshit until Lp(a) data?
0 · Reply
laaarsas
laaarsas Aug. 20 at 7:27 PM
$SLN retards selling this off. Back to where we where before best in disease results. Completely ridiculous. This will be 5-10x in three years, and should be 25 USD now.
1 · Reply
GenralP
GenralP Aug. 20 at 1:38 PM
$SLN wtf is this price action on this stock good lord
0 · Reply
laaarsas
laaarsas Aug. 20 at 11:31 AM
$SLN PUMP THIS FKN PUMP IT ALREADY
2 · Reply
JeremyDanie
JeremyDanie Aug. 19 at 7:24 PM
$SLN https://seekingalpha.com/article/4938417-silence-therapeutics-making-some-recent-noise?gt=92141d81767caad6
0 · Reply
GenralP
GenralP Aug. 19 at 3:56 PM
$SLN can we get this show on the road?
0 · Reply
MurrayKummer360
MurrayKummer360 Aug. 19 at 9:09 AM
$PSFE $ATAI $SLN $PR Paysafe remains tied to digital-payments adoption, atai Life Sciences remains focused on psychedelic and mental-health research, SLN remains clinical-stage and speculative, and PR remains execution-dependent. I'm watching payment volumes, clinical data, funding, and liquidity.
0 · Reply
laaarsas
laaarsas Aug. 19 at 8:18 AM
$SLN REALISE THIS IS GOING TO 25!!!!
0 · Reply
laaarsas
laaarsas Aug. 18 at 6:36 PM
$SLN this should go up so much
0 · Reply
laaarsas
laaarsas Aug. 18 at 7:39 AM
$SLN TRENDING MFS THIS IS BIG THIS IS BIG!!!
0 · Reply
nnnuuu
nnnuuu Aug. 18 at 6:59 AM
$SLN averaged up on that recent dip post-offering, seeing the PV data in the flesh and with upcoming (really, imminent) lp(a) optionality gives me confidence topping up at these levels.
0 · Reply
JeremyDanie
JeremyDanie Aug. 18 at 1:51 AM
0 · Reply
laaarsas
laaarsas Aug. 17 at 11:11 PM
$SLN CLIMB AND DANCE MFS. CLIMB AND DANCE
0 · Reply